Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus-Reference-Cited by-同舟云学术

Constitutive low expression of antiviral effectors sensitizes melanoma cells to a novel oncolytic virus

Published:2020-12-14 Issue:9 Volume:148 Page:2321-2334
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Intl Journal of Cancer

Author:

Dellac Sarah¹,Ben‐Dov Hamutal¹,Raanan Ayala¹,Saleem Hanna¹,Zamostiano Rachel¹,Semyatich Rinat¹,Lavi Sara¹,Witz Isaac P.¹^ORCID,Bacharach Eran¹,Ehrlich Marcelo¹^ORCID

Affiliation:

1. Shmunis School of Biomedicine and Cancer Research, George S. Wise Faculty of Life Sciences Tel Aviv University Tel Aviv Israel

Funder

Dr. Miriam and Sheldon G. Adelson Medical Research Foundation

Israel Cancer Association

Israel Science Foundation

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33401

Reference50 articles.

1. Clonal Heterogeneity and Tumor Evolution: Past, Present, and the Future

2. Cancer immunoediting: antigens, mechanisms, and implications to cancer immunotherapy

3. MHC class I down‐regulation: tumour escape from immune surveillance? (Review);Bubenik J;Int J Oncol,2004

4. Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion

5. Combined genetic and epigenetic interferences with interferon signaling expose prostate cancer cells to viral infection

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Arrest and Attack: Microtubule-Targeting Agents and Oncolytic Viruses Employ Complementary Mechanisms to Enhance Anti-Tumor Therapy Efficacy;Genes;2024-09-11

2. Integrating innate and adaptive immunity in oncolytic virus therapy;Trends in Cancer;2023-10

3. Lipocalin-2 regulates the expression of interferon-stimulated genes and the susceptibility of prostate cancer cells to oncolytic virus infection;European Journal of Cell Biology;2023-06

4. Engineering strategies to enhance oncolytic viruses in cancer immunotherapy;Signal Transduction and Targeted Therapy;2022-04-06

5. USP18 and USP20 restrict oHSV-1 replication in resistant human oral squamous carcinoma cell line SCC9 and affect the viability of SCC9 cells;Molecular Therapy - Oncolytics;2021-12